Dosing and Administration

Only RELEXXII offers branded 45 mg and 63 mg strengths

RELEXXII provides flexible methylphenidate dosing options, including 45 mg and 63 mg in-between strengths, to support ADHD medication titration and individualized treatment decisions.

RELEXXII strengths compared with equivalent strengths of other ADHD medication brands
RELEXXII® 18 mg 27 mg 36 mg 45 mg 54 mg 63 mg 72 mg
CONCERTA® 18 mg 27 mg 36 mg 54 mg
FOCALIN® XR 5 mg 10 mg 15 mg 20 mg
COTEMPLA XR-ODT® 8.6 mg 17.3 mg 25.9 mg
APTENSIO® XR 10 mg 15 mg 20 mg 30 mg 40 mg
QUILLICHEW ER® 20 mg 30 mg 40 mg
RITALIN® LA 10 mg 20 mg 30 mg 40 mg

Strengths listed for other brands are derived from ADHD Medication Guide dose conversions. Some products above may offer strengths that exceed 72 mg dose equivalents. All trademarks are the property of their respective owners. Source: adhdmedicationguide.com

ADHD Medication Titration and Management May Be Simplified With Multiple Strengths Available In 9 mg Increments1,2

RELEXXII methylphenidate dosing options for ADHD medication titration in 9 mg increments: 18, 27, 36, 45, 54, 63 and 72 mg

Initiating RELEXXII for ADHD treatment

Available in seven strengths, RELEXXII offers multiple methylphenidate dosing options to support individualized ADHD treatment and medication titration.

Dosage Recommendations for RELEXXII1 Pediatric Patients 6 to 17 Years and Adults
Dosage recommendations for RELEXXII in pediatric patients 6 to 17 years and adults
Patient
Population		 Recommended RELEXXII
Starting Dosage		 RELEXXII
Dosage Range
Pediatric Patients
6 to 12 years 18 mg once daily 18 mg to 54 mg once daily
13 to 17 years 18 mg once daily 18 mg to 72 mg once daily(not to exceed 2 mg/kg/day)
Adults
18 (up to 65) years 18 mg or 36 mg once daily 18 mg to 72 mg once daily

Switching patients to RELEXXII extended-release methylphenidate HCl

When transitioning to RELEXXII, guidance may help support the appropriate methylphenidate dose adjustment.

Converting From Methylphenidate Regimens to RELEXXII1 Dosage Recommendations for Patients
Converting from methylphenidate regimens to RELEXXII: dosage recommendations for patients
Current Methylphenidate
Daily Dosage 		Recommended RELEXXII
Starting Dosage
5 mg methylphenidate two to three times daily 18 mg once daily in the morning
10 mg methylphenidate two to three times daily 36 mg once daily in the morning
15 mg methylphenidate two to three times daily 54 mg once daily in the morning
20 mg methylphenidate two to three times daily 72 mg once daily in the morning

How RELEXXII Should be Administered

RELEXXII extended-release methylphenidate tablets should be taken orally once daily in the morning, with or without food.1

RELEXXII tablets must be swallowed whole with the aid of liquids and must not be chewed, divided, or crushed.1

Prescription pad marked Rx DAW 1 (Dispense as Written)

Help Patients Maintain Continuity During ADHD Treatment

Specify DAW 1 on every prescription to help support ADHD treatment continuity and reduce pharmacy substitutions.

Who’s right for RELEXXII?

For Patients Who Need an Individualized ADHD
Medication Dose

Explore patient scenarios and considerations that may help guide personalized ADHD treatment decisions.

VIEW PATIENT SCENARIOS
Smiling man climbing a red indoor rock wall

References: 1. RELEXXII package insert. Vertical Pharmaceuticals, LLC. 2. Data on file, Osmotica Pharmaceuticals.

All individuals depicted are models used for illustrative purposes only.

ADHD=attention deficit hyperactivity disorder

You Are About To Leave This Website

By clicking continue, this link will take you to a website to which Alora Pharmaceuticals’ Policies & Terms of Use do not apply. Alora and its subsidiaries do not control the content or accuracy of third-party websites and assume no responsibility for their use.
CONTINUE